Invention Grant
- Patent Title: Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
-
Application No.: US12825631Application Date: 2010-06-29
-
Publication No.: US08383644B2Publication Date: 2013-02-26
- Inventor: Adnan M. M. Mjalli , Christopher Behme , Daniel P. Christen , Devi Reddy Gohimukkula , Dharma Rao Polisetti , James Quada , Jennifer L. R. Freeman , Kalpathy Santhosh , Muralidhar Bondlela , Mustafa Guzel , Ravindra Reddy Yarragunta , Robert Carl Andrews , Stephen Thomas Davis , Thomas Scott Yokum
- Applicant: Adnan M. M. Mjalli , Christopher Behme , Daniel P. Christen , Devi Reddy Gohimukkula , Dharma Rao Polisetti , James Quada , Jennifer L. R. Freeman , Kalpathy Santhosh , Muralidhar Bondlela , Mustafa Guzel , Ravindra Reddy Yarragunta , Robert Carl Andrews , Stephen Thomas Davis , Thomas Scott Yokum
- Applicant Address: US NC High Point
- Assignee: TransTech Pharma, Inc.
- Current Assignee: TransTech Pharma, Inc.
- Current Assignee Address: US NC High Point
- Agent Samuel B. Rollins
- Main IPC: C07D491/056
- IPC: C07D491/056 ; A61K31/436
Abstract:
The present invention is directed to substituted azoanthracene derivatives or pharmaceutically acceptable salts thereof that modulate the human GLP-1 receptor and that may be useful in the treatment of diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial, such as diabetes mellitus type 2. The invention is also directed to pharmaceutical compositions comprising these compounds and to the use of these compounds and compositions in the treatment of such diseases, disorders, or conditions in which modulation of the human GLP-1 receptor is beneficial.
Public/Granted literature
- US20110160198A1 SUBSTITUTED AZOANTHRACENE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF USE THEREOF Public/Granted day:2011-06-30
Information query
